Skip navigation

Unrivaled Content and Networking to Drive Innovative Promotional Programs

February 12-13, 2019
  • Philadelphia, PA

Speaker Programs 2019 serves as the life sciences industry’s ONLY educational forum focused on critical marketing, operations and compliance matters for sustaining speaker programs. Addressing the ever-evolving practices of speaker program management and development, this highly regarded, 11th annual event provides valuable insights from expert thought-leaders, including updates on key training techniques for accurately conducting speaker programs.

DISTINGUISHED CONFERENCE CO-CHAIRS

Kathleen Walpole Speaker Program
Solutions Leader
AstraZeneca

Rore Middleton Director, U.S.
Compliance and Ethics
Alexion Pharmaceuticals

PRACTICAL INSIGHTS FROM INDUSTRY’S LEADING SPEAKER PROGRAM EXPERTS

Jenny Shire
Director, Travel, Professional Programs & Operations
Daiichi Sankyo, Inc.

Sheea Sybblis
Senior Counsel
Boehringer Ingelheim

Brian R. Howe, Esq.
Corporate Counsel, Litigation
Celgene

Shannon Gunther
Deputy Director,
Operational Excellence
Bayer

Ishita Arora
Compliance Manager
Horizon Pharma

Lisa Snyder
Senior Director, HCP Engagement and Monitoring
Regeneron Pharmaceuticals

Emily Honig
Corporate Counsel, Office of Business Integrity and Ethics
Vertex Pharmaceuticals

Lacey Luxon
Manager, Speaker Programs
Myriad Genetics

Ed Rauscher
Director – Promotional
Event Management,
Business Operations
Sanofi Genzyme

INTERACTIVE DISCUSSIONS AND COMPELLING CONTENT
  • Consider the value of current speaker programs and how to transition to a new approach for speaker program execution
  • Address best practices for developing speaker program content for specialty/rare disease products
  • Uncover new developments in state transparency legislation and spend limitations within New Jersey, California and more
  • Discuss recent investigations and enforcement actions and identify current areas of greatest risk
  • Hear how to accurately train your field reps and ensure they can take proper action during a speaker program
  • Determine how to control FMV challenges, venue selection processes and repeat attendance
  • Examine challenges of implementing virtual speaker programs to ensure an effective digital strategy
  • Anticipate how to effectively manage off-label risks
  • Identify company policies regarding thresholds/meal caps and other HCP costs

Previous Attendee Acclaim:

If you work in the field of biopharm speaker programs, this is simply a must-attend event!

CEO, MedPoint Digital

This conference is extremely insightful. Brings all
of the newest technologies and techniques
to the surface of speaker programs.

Field Programs Coordinator, Regeneron Pharmaceuticals

The overall two day conference provided excellent
information as well as great insight into current
and future pharmaceutical trends.

Senior Marketing Associate, Takeda Oncology

Speaker Programs 2019

Unrivaled Content and Networking to Drive Innovative Promotional Programs

Speaker Programs 2019 serves as the life sciences industry’s ONLY educational forum focused on critical marketing, operations and compliance matters for sustaining speaker programs. Addressing the ever-evolving practices of speaker program management and development, this highly regarded, 11th annual event provides valuable insights from expert thought-leaders, including updates on key training techniques for accurately conducting speaker programs.

DISTINGUISHED CONFERENCE CO-CHAIRS

Kathleen Walpole Speaker Program
Solutions Leader
AstraZeneca

Rore Middleton Director, U.S.
Compliance and Ethics
Alexion Pharmaceuticals

PRACTICAL INSIGHTS FROM INDUSTRY’S LEADING SPEAKER PROGRAM EXPERTS

Jenny Shire
Director, Travel, Professional Programs & Operations
Daiichi Sankyo, Inc.

Sheea Sybblis
Senior Counsel
Boehringer Ingelheim

Brian R. Howe, Esq.
Corporate Counsel, Litigation
Celgene

Shannon Gunther
Deputy Director,
Operational Excellence
Bayer

Ishita Arora
Compliance Manager
Horizon Pharma

Lisa Snyder
Senior Director, HCP Engagement and Monitoring
Regeneron Pharmaceuticals

Emily Honig
Corporate Counsel, Office of Business Integrity and Ethics
Vertex Pharmaceuticals

Lacey Luxon
Manager, Speaker Programs
Myriad Genetics

Ed Rauscher
Director – Promotional
Event Management,
Business Operations
Sanofi Genzyme

INTERACTIVE DISCUSSIONS AND COMPELLING CONTENT
  • Consider the value of current speaker programs and how to transition to a new approach for speaker program execution
  • Address best practices for developing speaker program content for specialty/rare disease products
  • Uncover new developments in state transparency legislation and spend limitations within New Jersey, California and more
  • Discuss recent investigations and enforcement actions and identify current areas of greatest risk
  • Hear how to accurately train your field reps and ensure they can take proper action during a speaker program
  • Determine how to control FMV challenges, venue selection processes and repeat attendance
  • Examine challenges of implementing virtual speaker programs to ensure an effective digital strategy
  • Anticipate how to effectively manage off-label risks
  • Identify company policies regarding thresholds/meal caps and other HCP costs

Previous Attendee Acclaim:

If you work in the field of biopharm speaker programs, this is simply a must-attend event!

CEO, MedPoint Digital

This conference is extremely insightful. Brings all
of the newest technologies and techniques
to the surface of speaker programs.

Field Programs Coordinator, Regeneron Pharmaceuticals

The overall two day conference provided excellent
information as well as great insight into current
and future pharmaceutical trends.

Senior Marketing Associate, Takeda Oncology